121 related articles for article (PubMed ID: 11589302)
1. Selective susceptibility of transformed T lymphocytes to induction of apoptosis by PSC 833, an inhibitor of P-glycoprotein.
Azare J; Pankova-Kholmyansky I; Salnikow K; Cohen D; Flescher E
Oncol Res; 2001; 12(8):315-23. PubMed ID: 11589302
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
Lehne G; Rugstad HE
Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
[TBL] [Abstract][Full Text] [Related]
3. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
6. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
Goulding CW; Giuliano AE; Cabot MC
Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
[TBL] [Abstract][Full Text] [Related]
7. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
Lopes EC; Scolnik M; Alvarez E; Hajos SE
Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
[TBL] [Abstract][Full Text] [Related]
8. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
Cabot MC; Giuliano AE; Han TY; Liu YY
Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
[TBL] [Abstract][Full Text] [Related]
9. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells.
Wang H; Giuliano AE; Cabot MC
Mol Cancer Ther; 2002 Jul; 1(9):719-26. PubMed ID: 12479368
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
Pallis M; Russell N
Blood; 2000 May; 95(9):2897-904. PubMed ID: 10779437
[TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
[TBL] [Abstract][Full Text] [Related]
12. Effects of ceramide inhibition on radiation-induced apoptosis in human leukemia MOLT-4 cells.
Takahashi E; Inanami O; Asanuma T; Kuwabara M
J Radiat Res; 2006 Mar; 47(1):19-25. PubMed ID: 16571915
[TBL] [Abstract][Full Text] [Related]
13. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
Cabot MC; Han TY; Giuliano AE
FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
Lehne G; De Angelis P; den Boer M; Rugstad HE
Leukemia; 1999 May; 13(5):768-78. PubMed ID: 10374882
[TBL] [Abstract][Full Text] [Related]
15. Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro.
Sadanand V; Kankesan J; Yusuf A; Stewart C; Rutka JT; Thiessen JJ; Ling V; Rao PM; Rajalakshmi S; Sarma DS
Cancer Lett; 2003 Jul; 198(1):21-7. PubMed ID: 12893426
[TBL] [Abstract][Full Text] [Related]
16. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3-like activity is necessary but not sufficient for daunorubicin-induced apoptosis in Jurkat human lymphoblastic leukemia cells.
Turnbull KJ; Brown BL; Dobson PR
Leukemia; 1999 Jul; 13(7):1056-61. PubMed ID: 10400421
[TBL] [Abstract][Full Text] [Related]
18. A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells.
Turella P; Filomeni G; Dupuis ML; Ciriolo MR; Molinari A; De Maria F; Tombesi M; Cianfriglia M; Federici G; Ricci G; Caccuri AM
J Biol Chem; 2006 Aug; 281(33):23725-32. PubMed ID: 16769721
[TBL] [Abstract][Full Text] [Related]
19. A bioassay for the activity of PSC 833 in human serum for modulation of P-glycoprotein-mediated multidrug resistance.
Uchiyama-Kokubu N; Watanabe T; Nakajima M
Anticancer Drugs; 2000 Aug; 11(7):583-90. PubMed ID: 11036963
[TBL] [Abstract][Full Text] [Related]
20. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.
Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B
Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]